Philip Beer, Chief Scientific Officer of Step Pharma, Paris, and Honorary Professor of Translational Medicine in York, presented a webinar exploring one of the key challenges that we are currently facing when applying genomic testing in cancer.
In this blog post, we will highlight the key takeaway messages from his webinar.
Congenica is an England-based digital health company that offers solutions such as AI-powered clinical decision support and genomic data analysis for the healthcare industry.